Key Statistics for NOVOB
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (DKK) (ttm)
|Est. EPS (DKK) (12/2013)
|Est. PEG Ratio
|Market Cap (M DKK)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (DKK)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for NOVOB
- Net Income (M/DKK)
Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.
More Company Profile & Key Executives for NOVOB
|Lars Rebien SorensenPresident/CEO||Jesper BrandgaardExec VP/CFO|
|Kaare SchultzExec VP/COO||Mads Krogsgaard ThomsenExec VP/Chief Science Officer|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries